SROBF.EBM

Society for Radiation Oncology, Biology and Physics - Czech Republic. (Association of specialists in radiation oncology, radiobiology and radiology physics.)

[SROBF.EBM @SROBF_EBM]

Long term outcomes of sexual function in the PACE-A: radical prostatectomy vs SBRT for early localised prostate cancer #ASTRO2026 Conclusion: Prostatectomy was associated with
substantially greater deterioration in sex. function and worse overall sex. outcomes than SBRT at 5 ys.

[SROBF.EBM @SROBF_EBM]

Initial Results of NRG Oncology NRG-GI003: A Phase III
Randomized Trial of Protons vs. Photons for HCC #ASTRO2026
Conclusion: Proton therapy did not improve OS, PFS, LP, or AEs in patients with advanced HCC.
Clinical Trial Number: NCT03186898.

[SROBF.EBM @SROBF_EBM]

International Consensus Guidelines for Radiation Target Volume Delineation for Skull Base Chordoma—A Particle Therapy Co-operative Group Initiative - International Journal of Radiation Oncology, Biology, Physics https://t.co/74KJgqVgrl

[SROBF.EBM @SROBF_EBM]

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial - The Lancet https://t.co/athy4asOsF

[SROBF.EBM @SROBF_EBM]

Radiation Therapy for Pancreatic Cancer: An #ASTRO Clinical Practice Guideline - Practical Radiation Oncology https://t.co/TMZzj2iTti

[ESTRO @ESTRO_RT]

ESTRO Consensus Recommendations on Total Skin Electron Beam Technique - Endorsed by ILROG.
Published in phiRO 👉 https://t.co/LjwnaXWI2X

#RadiationOncology #MedicalPhysics #SkinCancer #radonc #medPhys @ILROGTeam

[SROBF.EBM @SROBF_EBM]

Acute adverse events of hypofractionated whole-breast radiotherapy with a simultaneous-integrated boost – Results from the randomized controlled HYPOSIB-trial (ARO 2013-05) - International Journal of Radiation Oncology, Biology, Physics https://t.co/SZlpMdjOWV

[SROBF.EBM @SROBF_EBM]

Acute radiation side effects of proton versus photon therapy following surgery for early breast cancer, a sub-study of the randomised controlled DBCG Proton Trial - International Journal of Radiation Oncology, Biology, Physics https://t.co/0OZHgbp3wy

[SROBF.EBM @SROBF_EBM]

Clinical Hypothyroidism After Proton Versus Photon Regional Nodal Irradiation: A Prospective Correlative Study Within the RADCOMP Randomized Trial - International Journal of Radiation Oncology, Biology, Physics https://t.co/jNC7aq2H3s

[SROBF.EBM @SROBF_EBM]

Long-Term Outcomes After Proton Therapy Versus Intensity Modulated Photon Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: Post Hoc Analysis of a Prospective Randomized Trial - IJROBP https://t.co/Acjn31khXZ

[SROBF.EBM @SROBF_EBM]

Long-term outcomes after proton therapy vs. intensity-modulated photon radiotherapy with concurrent chemotherapy for locally advanced NSCLC: post-hoc analysis of a prospective randomized trial - IJROBP https://t.co/Acjn31khXZ

[SROBF.EBM @SROBF_EBM]

Hypofractionated breast RT for 1 week versus 3 weeks (FAST-Forward): 10-year efficacy and late normal tissue effects from a multicentre, phase 3, randomised controlled trial and 5-year efficacy results from a axillary substudy - The Lancet Oncology https://t.co/3oTtoPdxFH

[SROBF.EBM @SROBF_EBM]

Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 study - The Lancet Oncology https://t.co/zkxOXaR3ph

[SROBF.EBM @SROBF_EBM]

ESTRO-EORTC expert guideline on target delineation and radiotherapy details for stage I–III small cell lung cancer - Radiotherapy and Oncology https://t.co/xmq3cyE95g

[SROBF.EBM @SROBF_EBM]

ESTRO clinical practice guideline on radiotherapy for adult soft tissue sarcoma of the extremities and trunk wall – Endorsed by ASTRO - Radiotherapy and Oncology https://t.co/IHD9B7onJ5

[SROBF.EBM @SROBF_EBM]

Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial - The Lancet https://t.co/x8RIH0MEe3

[SROBF.EBM @SROBF_EBM]

Effects of Radiotherapy in Normal Tissue | New England Journal of Medicine https://t.co/eVttjwlY4B

[SROBF.EBM @SROBF_EBM]

International Radiosurgery Oncology Consortium of the Kidney (IROCK) Contouring Guidelines for Renal Cell Carcinoma treated with Stereotactic Ablative Radiotherapy - International Journal of Radiation Oncology, Biology, Physics https://t.co/8ngn97CRLd

[SROBF.EBM @SROBF_EBM]

Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial - The Lancet Oncology https://t.co/Jxqyn2d9bz

[Shankar Siva @_ShankarSiva]

WOW! 🧠METIS trial (n=298) in #lungcancer brain mets: SRS ➕ TTFields ⚡vs SRS alone
✅ TTFields delays intracranial progression (HR 0.72, p=0.044)
📉12-mo progression: 47% vs 59%; ⬆️ with immunotherapy (HR 0.63)
❌No QoL / cognition decline; AEs mild skin
#ASTRO25 #RadOnc #lcsm